[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- ["The Most Critical Metal for Global Economies"]() [Find Out How This Is Good News for Commodity Investors.](=) --------------------------------------------------------------- July 18, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [What Investors Don't Know: Communist China Could Profit Billions From The World "Going Green."](=) =Who controls 80% of the works lithium supply (the most important metal for building EV batteries)? China! And if you're outraged by that fact, then you'll love hearing how this western company is fighting back… [See How This Lithium Play Could Explode](=) = --------------------------------------------------------------- [Sharps Compliance, SMED]( Recent Analyst Action: Michael E., analyst at Stifel Nicolaus, reiterates coverage on [Sharps Compliance (SMED)](=)in the Services sector with a Hold rating and a price target of $8.75 (5 days ago). - Recent Price: $8.5 - Average Analyst Price Target: $7.38 (-13.18%) - Market Cap: $164.77M [TipRanks.com]( also reports that [Sharps Compliance](=)currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $7.38. The target pricing ranges from a high forecast of $8.75 down to a low forecast of $6.00. [Sharps Compliance (SMED)](=)’s last closing price was $8.5 which would put the average price target at $7.38. Here are 3rd party ratings for [SMED](: - TipRanks.com: Hold - TradingView.com: n/a - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Top 31% (79 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [2022's Hottest Penny Stocks [Warning: This List May Surprise You]](=) There’s an entire universe of penny stocks, Wall Street doesn’t want people to know about. Why? Because they’re too small to recommend. Even if they are the most innovative, entrepreneurial companies in America today... that could make money for investors, hand over fist… to the tune of 6,486% in just one year… Most investors will never hear about these high-flying stocks from Wall Street. [Continue for the full briefing.](=) = --------------------------------------------------------------- [Faraday Future Intelligent Electric, FFIE](=) Recent Analyst Action: Michael Ward, analyst at Benchmark Co., reiterates coverage on [Faraday Future Intelligent Electric (FFIE)](in the Consumer Goods sector with a Buy rating and a price target of $10.00 (1 month ago). - Recent Price: $7.52 - Average Analyst Price Target: $10.00 (32.98%) - Market Cap: $2.27B [TipRanks.com]( also reports that [Faraday Future Intelligent Electric](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $10.00. [Faraday Future Intelligent Electric (FFIE)](’s last closing price was $7.52 which would put the average price target at $10.00. Here are 3rd party ratings for [FFIE](=): - TipRanks.com: Moderate Buy - TradingView.com: n/a - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 37% (93 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [Apyx Medical, APYX]( Recent Analyst Action: Matthew O'Brien, analyst at Piper Sandler, reiterates coverage on [Apyx Medical (APYX)]()in the Healthcare sector with a Buy rating (12 hours ago). - Recent Price: $8.085 - Average Analyst Price Target: $12.50 (54.61%) - Market Cap: $258.40M [TipRanks.com]( also reports that [Apyx Medical]()currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.50. The target pricing ranges from a high forecast of $14.00 down to a low forecast of $11.00. [Apyx Medical (APYX)]()’s last closing price was $8.085 which would put the average price target at $12.50. Here are 3rd party ratings for [APYX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 49% (127 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [The Inflation Cure No One is Talking About]( forensic accountant who’s been called in to consult with the U.S. Pentagon five times in the past year says almost no one understands the next really big trend in our country. It could tame inflation, fix so many of our problems, and make some folks massive returns along the way. --------------------------------------------------------------- [EVgo, EVGO]() Recent Analyst Action: Vikram Bagri, analyst at Needham, reiterates coverage on [EVgo (EVGO)](=)in the Consumer Goods sector with a Hold rating (3 days ago). - Recent Price: $7.84 - Average Analyst Price Target: $12.44 (60.20%) - Market Cap: $1.92B [TipRanks.com]() also reports that [EVgo](=)currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.44. The target pricing ranges from a high forecast of $16.00 down to a low forecast of $5.50. [EVgo (EVGO)](=)’s last closing price was $7.84 which would put the average price target at $12.56. Here are 3rd party ratings for [EVGO](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 37% (93 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- [Enovix, ENVX](=) Recent Analyst Action: Gabriel Daoud, analyst at Cowen & Co., reiterates coverage on [Enovix (ENVX)]()in the Industrial Goods sector with a Buy rating and a price target of $20.00 (3 weeks ago). - Recent Price: $10.77 - Average Analyst Price Target: $20.67 (91.92%) - Market Cap: $1.56B [TipRanks.com]( also reports that [Enovix]()currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.67. The target pricing ranges from a high forecast of $22.00 down to a low forecast of $20.00. [Enovix (ENVX)]()’s last closing price was $10.77 which would put the average price target at $20.67. Here are 3rd party ratings for [ENVX](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 38% (96 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [The Forever Battery: Making Gas Guzzlers Obsolete](=) =Only 2% of cars sold in the U.S. today are electric vehicles… but that’s about to change — FAST. A new battery breakthrough is ready to hit the market. It could revolutionize the $2 trillion automotive industry … and could soon make gas guzzlers obsolete. This technology is predicted to cause a 1,500% surge in electric vehicle sales over the next four years. The company pioneering this new battery could be the investment of a lifetime. [Click here for details.](=) = --------------------------------------------------------------- [Natera, NTRA]() Recent Analyst Action: David Westenberg, analyst at Piper Sandler, reiterates coverage on [Natera (NTRA)]()in the Healthcare sector with a Buy rating and a price target of $60.00 (2 months ago). - Recent Price: $45.68 - Average Analyst Price Target: $73.89 (61.76%) - Market Cap: $4.41B [TipRanks.com](=) also reports that [Natera]()currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $73.89. The target pricing ranges from a high forecast of $100.00 down to a low forecast of $54.00. [Natera (NTRA)]()’s last closing price was $45.68 which would put the average price target at $73.89. Here are 3rd party ratings for [NTRA](): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 32% (80 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- [TG Therapeutics, TGTX]() Recent Analyst Action: Edward White, analyst at H.C. Wainwright, reiterates coverage on [TG Therapeutics (TGTX)](=)in the Healthcare sector with a Buy rating (3 weeks ago). - Recent Price: $6.28 - Average Analyst Price Target: $13.86 (43.31%) - Market Cap: $895.50M [TipRanks.com]() also reports that [TG Therapeutics](=)currently has 8 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $13.86. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $5.00. [TG Therapeutics (TGTX)](=)’s last closing price was $6.28 which would put the average price target at $9.00. Here are 3rd party ratings for [TGTX](): - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 49% (127 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Biden Warns: China Could "Eat ur Lunch" When it Comes to Lithium](=) =Pres. Biden recently warned about China's dominance when it comes to lithium demand, stating, "if we don't get moving, they're going to eat our lunch." One junior mining company in South America is looking to become a strong link in the lithium supply chain due to a monster acquisition. [Get the full scoop on this investment opportunity here.](=) = --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954